Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes
Authors
Keywords
-
Journal
Molecular BioSystems
Volume 12, Issue 3, Pages 711-720
Publisher
Royal Society of Chemistry (RSC)
Online
2016-01-04
DOI
10.1039/c5mb00700c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract 2374: Mir-29/Hsp47 regulate breast cancer progression by modulating the ECM transcription network
- (2015) Jieqing Zhu et al. CANCER RESEARCH
- Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells
- (2015) Qian Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer
- (2015) Peng Wang et al. NUCLEIC ACIDS RESEARCH
- H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells
- (2015) HONG SUN et al. ONCOLOGY REPORTS
- Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
- (2015) Yi Shen et al. Oncotarget
- Chromatin states modify network motifs contributing to cell-specific functions
- (2015) Hongying Zhao et al. Scientific Reports
- Abstract 3268: Differences in expression of lncRNAs in breast tumor, adjacent normal-appearing breast tissue, and normal breast tissue from healthy donors
- (2015) Erin Wagner et al. CANCER RESEARCH
- Abstract 988: A mouse model gene expression database reveals E2Fs as key regulators of breast cancer metastasis
- (2015) Daniel Hollern et al. CANCER RESEARCH
- Combining functional genomics strategies identifies modular heterogeneity of breast cancer intrinsic subtypes
- (2015) Nima Pouladi et al. BioData Mining
- Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
- (2014) Jian Kang et al. BMC CANCER
- Abstract P6-04-25: Genomic Deregulation and Therapeutic Role of Nemo-like Kinase in Luminal B Breast Cancer
- (2014) X Cao et al. CANCER RESEARCH
- Abstract 869: PTEN/PI3K oncogenic pathway profiling informs an in vivo synergistic therapeutic model for basal-like breast cancer.
- (2014) Lao H. Saal et al. CANCER RESEARCH
- Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer
- (2014) Li Wang et al. PLoS One
- Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity
- (2014) Aleix Prat et al. Scientific Reports
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Molecular and Cellular Heterogeneity in Breast Cancer
- (2013) Ashley G. Rivenbark et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases
- (2013) Christoph Wille et al. MOLECULAR BIOLOGY OF THE CELL
- Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
- (2013) Chunquan Li et al. NUCLEIC ACIDS RESEARCH
- Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
- (2012) Edita Aksamitiene et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
- (2012) Alexander H Stegh EXPERT OPINION ON THERAPEUTIC TARGETS
- GENCODE: The reference human genome annotation for The ENCODE Project
- (2012) J. Harrow et al. GENOME RESEARCH
- NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells
- (2012) Zhujun Tan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer
- (2012) Daichi Shigemizu et al. PLoS Computational Biology
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains
- (2010) Zhi-Ping Liu et al. BMC Systems Biology
- Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
- (2010) Takashi Nakakuki et al. CELL
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo
- (2010) A. Beliveau et al. GENES & DEVELOPMENT
- Retinoids regulate stem cell differentiation
- (2010) Lorraine J. Gudas et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
- (2010) David S Yee et al. Molecular Cancer
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Phospho-control of TGF-β superfamily signaling
- (2008) Katharine H Wrighton et al. CELL RESEARCH
- STRING 8--a global view on proteins and their functional interactions in 630 organisms
- (2008) L. J. Jensen et al. NUCLEIC ACIDS RESEARCH
- GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
- (2008) M Mourtada-Maarabouni et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started